Use of the oxygen gradient ektacytometry in the dose titration of hydroxyurea therapy in children with sickle cell disease

Int J Lab Hematol. 2024 Apr;46(2):390-394. doi: 10.1111/ijlh.14208. Epub 2023 Dec 17.

Authors

Maite E Houwing¹, Jennifer Bos², Richard van Wijk², Eduard J van Beers³, Marjon H Cnossen¹, Minke A E Rab^{2

4}; SCORE consortium

Collaborators

SCORE consortium:
E J van Beers, B J Biemond, M Beijlevelt, P P T Brons, M H Cnossen, C Eckhardt, K Fijnvandraat, H Heijboer, F Hofstede, J L H Kerkhoffs, A B U Mäkelburg, E Nur, C S Ootjers, P J de Pagter, E Rettenbacher, A W Rijneveld, S E M Schols, F J Smiers, M H Suiker, C F J van Tuijn, I van Vliet

Affiliations

¹ Department of Pediatric Hematology and Oncology, Erasmus MC-Sophia Children's Hospital, University Medical Center Rotterdam, Rotterdam, The Netherlands.
² Central Diagnostic Laboratory - Research, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
³ Van Creveldkliniek, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
⁴ Department of Hematology, Erasmus Medical Center, University Medical Center Rotterdam, Rotterdam, The Netherlands.

PMID: 38105480
DOI: 10.1111/ijlh.14208

No abstract available

Publication types

Letter

MeSH terms

Anemia, Sickle Cell* / drug therapy
Child
Humans
Hydroxyurea* / therapeutic use
Oxygen

Substances

Hydroxyurea
Oxygen